Amyris, Inc. (AMRS) is an integrated renewable products company utilizing an industrial synthetic biology platform capable of taking genetically-engineered yeast to create select products derived from petroleum. The company utilizes Brazilian sugarcane as a primary feedstock which it uses to feed its yeast in large conventional fermentation vessels.
To date, Amyris has been largely focused on its primary building block molecule of farnesene. With farnesene, the company expects to address a diverse range of product markets including fuels, lubricants, polymers, flavors, and personal care products. With its technology, Amyris remains potentially poised in the future as a leading company in the field of industrial biotechnology.
Industrial biotechnology is the use of biological resources for the production of bio-based...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|